At ISHLT2025, ISHLT collaborated with Cradles to Crayons®, a nonprofit in Newton, MA USA providing kids with free essentials. ISHLT attendees made more than 350 donations of clothing for kids in need in the greater Boston area.

On this special episode of JHLT: The Podcast, the Digital Media Editors put their heads together to explore a few interesting topics from ISHLT2025, the ISHLT's 45th Annual Meeting & Scientific Sessions.

During the final General Session of the ISHLT’s 45th Annual Meeting & Scientific Sessions, ISHLT recognized outstanding achievements in research and groundbreaking scientific contributions.

During the 45th Annual Meeting & Scientific Sessions in Boston, ISHLT announced $250,000 USD in grants funded by the ISHLT Foundation to support research to advance heart and lung disease.

As announced at the ISHLT2025 meeting in Boston last month, Melissa Cousino, PhD, will serve as the Scientific Program Chair for the ISHLT’s 47th Annual Meeting & Scientific Sessions. Dr. Cousino will be the first non-physician ISHLT member to hold this position.

The ISHLT International Thoracic Organ Transplant (TTX) Registry hosted a special session at ISHLT2025 in Boston to highlight the recent progress in international data sharing with the ISHLT Registry following the challenges of evolving privacy regulations.

On 30 April, at the closing General Session at the ISHLT 45th Annual Meeting & Scientific Sessions in Boston, the ISHLT Foundation announced Daniel Goldstein, MD from Montefiore Medical Center in Bronx, NY USA as the 2025 recipient of the Francis D. Pagani, MD Endowed Mentorship Award.

The 2023 International Thoracic Organ Transplant (TTX) Registry Report is now available. This is a special report focuses on renal failure after thoracic organ transplantation.

ISHLT2025 featured multidisciplinary science and global collaboration. This was the largest ISHLT Annual Meeting ever, where over 4,500 attendees gathered in Boston, MA USA. Catch up on all the meeting highlights.

From among the more than 2,000 presentations in at the Annual Meeting in Boston, three abstracts were selected to receive awards to recognize excellence from early career investigators.

Barostim is a novel device therapy that works with GDMT to targets the neurohormonal pathways responsible for heart failure progression and symptoms. Watch this symposium recording from CVRx to learn more.

Final Day of ISHLT2025